246 related articles for article (PubMed ID: 28596197)
1. First evidence of genotype-phenotype correlations in Gorlin syndrome.
Evans DG; Oudit D; Smith MJ; Rutkowski D; Allan E; Newman WG; Lear JT
J Med Genet; 2017 Aug; 54(8):530-536. PubMed ID: 28596197
[TBL] [Abstract][Full Text] [Related]
2. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations.
Smith MJ; Beetz C; Williams SG; Bhaskar SS; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Bholah Z; Oudit D; Cheesman E; Kelsey A; McCabe MG; Newman WG; Evans DG
J Clin Oncol; 2014 Dec; 32(36):4155-61. PubMed ID: 25403219
[TBL] [Abstract][Full Text] [Related]
3. Medulloblastoma and other neoplasms in patients with heterozygous germline SUFU variants: A scoping review.
Lee SG; Evans G; Stephen M; Goren R; Bondy M; Goodman S
Am J Med Genet A; 2024 Jun; 194(6):e63496. PubMed ID: 38282294
[TBL] [Abstract][Full Text] [Related]
4. Differences in RNA and microRNA Expression Between PTCH1- and SUFU-mutated Medulloblastoma.
Gershanov S; Toledano H; Pernicone N; Fichman S; Michowiz S; Pinhasov A; Goldenberg-Cohen N; Listovsky T; Salmon-Divon M
Cancer Genomics Proteomics; 2021; 18(3):335-347. PubMed ID: 33893086
[TBL] [Abstract][Full Text] [Related]
5. Identification of a SUFU germline mutation in a family with Gorlin syndrome.
Pastorino L; Ghiorzo P; Nasti S; Battistuzzi L; Cusano R; Marzocchi C; Garrè ML; Clementi M; Scarrà GB
Am J Med Genet A; 2009 Jul; 149A(7):1539-43. PubMed ID: 19533801
[TBL] [Abstract][Full Text] [Related]
6. Mutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same.
Huq AJ; Walsh M; Rajagopalan B; Finlay M; Trainer AH; Bonnet F; Sevenet N; Winship IM
Fam Cancer; 2018 Oct; 17(4):601-606. PubMed ID: 29356994
[TBL] [Abstract][Full Text] [Related]
7. A Novel PTCH1 Frameshift Mutation Leading to Nevoid Basal Cell Carcinoma Syndrome.
Durmaz CD; Evans G; Smith MJ; Ertop P; Akay BN; Tuncalı T
Cytogenet Genome Res; 2018; 154(2):57-61. PubMed ID: 29544218
[TBL] [Abstract][Full Text] [Related]
8. SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature.
Mangum R; Varga E; Boué DR; Capper D; Benesch M; Leonard J; Osorio DS; Pierson CR; Zumberge N; Sahm F; Schrimpf D; Pfister SM; Finlay JL
Childs Nerv Syst; 2016 Dec; 32(12):2439-2446. PubMed ID: 27444290
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma.
Slade I; Murray A; Hanks S; Kumar A; Walker L; Hargrave D; Douglas J; Stiller C; Izatt L; Rahman N
Fam Cancer; 2011 Jun; 10(2):337-42. PubMed ID: 21188540
[TBL] [Abstract][Full Text] [Related]
10. Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.
Guerrini-Rousseau L; Dufour C; Varlet P; Masliah-Planchon J; Bourdeaut F; Guillaud-Bataille M; Abbas R; Bertozzi AI; Fouyssac F; Huybrechts S; Puget S; Bressac-De Paillerets B; Caron O; Sevenet N; Dimaria M; Villebasse S; Delattre O; Valteau-Couanet D; Grill J; Brugières L
Neuro Oncol; 2018 Jul; 20(8):1122-1132. PubMed ID: 29186568
[TBL] [Abstract][Full Text] [Related]
11. Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation.
Kijima C; Miyashita T; Suzuki M; Oka H; Fujii K
Fam Cancer; 2012 Dec; 11(4):565-70. PubMed ID: 22829011
[TBL] [Abstract][Full Text] [Related]
12. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.
Foulkes WD; Kamihara J; Evans DGR; Brugières L; Bourdeaut F; Molenaar JJ; Walsh MF; Brodeur GM; Diller L
Clin Cancer Res; 2017 Jun; 23(12):e62-e67. PubMed ID: 28620006
[TBL] [Abstract][Full Text] [Related]
13. Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG).
Guerrini-Rousseau L; Smith MJ; Kratz CP; Doergeloh B; Hirsch S; Hopman SMJ; Jorgensen M; Kuhlen M; Michaeli O; Milde T; Ridola V; Russo A; Salvador H; Waespe N; Claret B; Brugieres L; Evans DG
Fam Cancer; 2021 Oct; 20(4):317-325. PubMed ID: 33860896
[TBL] [Abstract][Full Text] [Related]
14. Multi-layered mutation in hedgehog-related genes in Gorlin syndrome may affect the phenotype.
Onodera S; Saito A; Hasegawa D; Morita N; Watanabe K; Nomura T; Shibahara T; Ohba S; Yamaguchi A; Azuma T
PLoS One; 2017; 12(9):e0184702. PubMed ID: 28915250
[TBL] [Abstract][Full Text] [Related]
15. Gorlin syndrome-induced pluripotent stem cells form medulloblastoma with loss of heterozygosity in
Ikemoto Y; Miyashita T; Nasu M; Hatsuse H; Kajiwara K; Fujii K; Motojima T; Kokido I; Toyoda M; Umezawa A
Aging (Albany NY); 2020 May; 12(10):9935-9947. PubMed ID: 32436863
[TBL] [Abstract][Full Text] [Related]
16. Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations.
Gururangan S; Robinson G; Ellison DW; Wu G; He X; Lu QR; McLendon R; Grant G; Driscoll T; Neuberg R
Pediatr Blood Cancer; 2015 Oct; 62(10):1855-8. PubMed ID: 25940061
[TBL] [Abstract][Full Text] [Related]
17. Retrospective family study of childhood medulloblastoma.
Ng D; Stavrou T; Liu L; Taylor MD; Gold B; Dean M; Kelley MJ; Dubovsky EC; Vezina G; Nicholson HS; Byrne J; Rutka JT; Hogg D; Reaman GH; Goldstein AM
Am J Med Genet A; 2005 May; 134(4):399-403. PubMed ID: 15759260
[TBL] [Abstract][Full Text] [Related]
18. PTCH2 is not a strong candidate gene for gorlin syndrome predisposition.
Smith MJ; Evans DG
Fam Cancer; 2022 Jul; 21(3):343-346. PubMed ID: 34170463
[TBL] [Abstract][Full Text] [Related]
19. Novel PTCH1 Mutation in a Young Child With Gorlin Syndrome and Medulloblastoma.
Gloude NJ; Yoon JM; Crawford JR
Pediatr Blood Cancer; 2016 Jun; 63(6):1128-9. PubMed ID: 26840755
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
